DJ Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ shed 1.60% to $7.37 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.03% to 52,747.32 and the NASDAQ Composite Index falling 0.22% to 24,876.91.
Novavax Inc. closed 38.43% short of its 52-week high of $11.97, which the company reached on February 26th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.29% to $266.73, Pfizer Inc. $(PFE)$ rose 2.35% to $25.25, and Merck & Co. Inc. $(MRK)$ rose 0.81% to $131.82.
Trading volume (2.9 M) remained 1.5 million below its 50-day average volume of 4.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2026.